Cme (CME) Net Cash Flow (2010 - 2026)

Cme (CME) has reported Net Cash Flow for 17 consecutive years, with -$7.2 billion the latest figure, recorded in Q2 2026.

• Quarterly Net Cash Flow fell 132.55% year-over-year to -$7.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $16.1 billion (down 71.57% YoY) and the FY2025 annual result came in at $62.3 billion, up 617.21% from the prior year.
• Net Cash Flow declined to -$7.2 billion in Q2 2026 per CME's latest filing, from $3.4 billion in the prior quarter.
• Over the last five years, Net Cash Flow for CME reached as high as $22.0 billion in Q2 2025 and fell as low as -$29.5 billion in Q2 2022.
• A 5-year average of -$29.5 million and a median of $2.3 billion in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2023 — Net Cash Flow slumped 1527.99% — and 2025, when it jumped 147958.82%.
• Year by year, Net Cash Flow stood at -$4.1 billion in 2022, then jumped by 187.35% to $3.6 billion in 2023, then tumbled by 99.76% to $8.5 million in 2024, then soared by 147958.82% to $12.6 billion in 2025, then plunged by 157.0% to -$7.2 billion in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$7.2 billion, $3.4 billion, and $12.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.